SCHEMBL3103722

SCHEMBL3103722

CCOC(=O)c1c(SCC)nc2cc(C(C)(C)C)ccc2c1C

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 4/20 0.41
ALDH1A1 P00352 4/20 0.41
KDM4E B2RXH2 2/20 0.41
MAPT P10636 5/20 0.41
LMNA P02545 3/20 0.41
TP53 P04637 1/20 0.39
PRNP P04156 1/20 0.37
KMT2A Q03164 3/20 0.37
MEN1 O00255 2/20 0.37
HPGD P15428 2/20 0.37
CYP1A2 P05177 1/20 0.37
CYP2D6 P10635 1/20 0.37
CYP2C9 P11712 1/20 0.37
CYP2C19 P33261 1/20 0.37
HTT P42858 1/20 0.37
GPR55 Q9Y2T6 1/20 0.37
F2 P00734 1/20 0.36
F10 P00742 1/20 0.36
PLG P00747 1/20 0.36
PRSS1 P07477 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1722147 0.87 DHODH (0.41) SMN1; SMN2ALDH1A1KDM4EMAPTLMNA
SCHEMBL1721271 0.84 TSHR (0.48) SMN1; SMN2ALDH1A1KDM4EMAPTLMNA
SCHEMBL3101230 0.83 SMN1; SMN2 (0.44) SMN1; SMN2ALDH1A1KDM4EMAPTLMNA
SCHEMBL3098815 0.82 ALDH1A1 (0.46) SMN1; SMN2ALDH1A1KDM4EMAPTLMNA
SCHEMBL1721217 0.82 ALDH1A1 (0.36) SMN1; SMN2ALDH1A1KDM4EMAPTLMNA
SCHEMBL1723157 0.82 ALOX5 (0.42) SMN1; SMN2ALDH1A1KDM4ELMNATP53
SCHEMBL1721482 0.82 ELANE (0.42) SMN1; SMN2ALDH1A1KDM4EMAPTLMNA
SCHEMBL3111516 0.80 ALOX5 (0.43) ALDH1A1KDM4EMAPTKMT2AMEN1
SCHEMBL3100597 0.80 SMN1; SMN2 (0.40) SMN1; SMN2ALDH1A1KDM4EMAPTLMNA
SCHEMBL3089500 0.79 MAPT (0.47) SMN1; SMN2ALDH1A1KDM4EMAPTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8399673-B2 Substituted 2-mercaptoquinoline-3-carboxamides as KCNQ2/3 modulators GRUENENTHAL GMBH (DE) 2013-03-19 US disclosed
US-20120252841-A1 Substituted 2-mercaptoquinoline-3-carboxamides as KCNQ2/3 modulators DRUNENTHAL GMBH (DE) 2012-10-04 US disclosed
US-20100234372-A1 SUBSTITUTED 2-MERCAPTOQUINOLINE-3-CARBOXAMIDES AS KCNQ2/3 MODULATORS GRUNENTHAL GMBH (DE) 2010-09-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100234372-A1 SUBSTITUTED 2-MERCAPTOQUINOLINE-3-CARBOXAMIDES AS KCNQ2/3 MODULATORS KCNQ1, KCNQ2, KCNJ2 SMN1; SMN2 4161/4885ALDH1A1 3187/4885KDM4E 367/4885
US-20120252841-A1 Substituted 2-mercaptoquinoline-3-carboxamides as KCNQ2/3 modulators KCNQ1, KCNQ2, KCNJ2 SMN1; SMN2 4161/4885ALDH1A1 3187/4885KDM4E 367/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.